A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

Keywords

Cell biology, Follicular dendritic cells, RANKL, Dendritic cell, CD40

References

• Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15.Judith G. Giri, Minoo Ahdieh, June Eisenman — 1994
• Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV‐1‐regulated protein gp34.Peter Baum, Richard B. Gayle, Fred Ramsdell — 1994
• A novel IL‐1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.Catherine J. McMahan, Jennifer L. Slack, Bruce Mosley — 1991
• TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40Mike Rothe, Vidya Sarma, Vishva M. Dixit — 1995
• Tumor necrosis factor receptor superfamily members and their ligands.Richard J. Armitage — 1994
• Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.Hikoaki Fukaura, Sally C. Kent, MATTHEW J. PIETRUSEWICZ — 1996
• The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.Craig A. Smith, Terry Farrah, Raymond G. Goodwin — 1994
• Basic local alignment search tool.Stephen F. Altschul, Warren Gish, Webb Miller — 1990
• Molecular and biological characterization of a murine ligand for CD40Richard J. Armitage, William C. Fanslow, L Strockbine — 1992
• Differential effect of transforming growth factor-beta 1 on the activation of human naive and memory CD4+ T lymphocytes.Rollen de Jong, René A. W. van Lier, Francis W. Ruscetti — 1994
• A method for constructing radiation hybrid maps of whole genomesMichael A. Walter, Dominique J. Spillett, Philip Thomas — 1994
• Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domainsA Larsen, Terri Davis, Benson M. Curtis — 1990
• Isolation of human T and B lymphocytes by E-rosette gradient centrifugation. Characterization of the isolated subpopulations.M. Madsen, Hans Erik Johnsen, Peter Wendelboe Hansen — 1980
• TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells*Brian Wong, Jaerang Rho, Joseph R. Arron — 1997
• The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms.Bruce Mosley, M P Beckmann, Carl J. March — 1989
• Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamilyRejean L. Idzerda, Carl J. March, Bruce Mosley — 1990
• Purification of his-tagged proteins in non-denaturing conditions suggests a convenient method for protein interaction studies.Alexander Hoffmann, Robert G. Roeder — 1991
• Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activationMarina Cella, Doris Scheidegger, Kathrin Palmer-Lehmann — 1996
• Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor.Raymond G. Goodwin, Mark R. Alderson, Craig A. Smith — 1993
• Function and activation of NF-kappa B in the immune system.Patrick A. Baeuerle, Thomas Henkel — 1994

Cited by

• Bone remodelling: a signalling system for osteoclast regulation.Ellen Filvaroff, Rik Derynck — 1998
• RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.Manuel Martín Serrano — 2000
• Molecular and cellular basis of bone resorptionReinhard Gruber — 2015
• Force‐Induced Osteoclast Apoptosis In Vivo Is Accompanied by Elevation in Transforming Growth Factor β and Osteoprotegerin ExpressionRobert J. White — 2000
• Cross-talk between RANKL and FRP-1/CD98 Systems: RANKL-mediated osteoclastogenesis is suppressed by an inhibitory anti-CD98 heavy chain mAb and CD98-mediated osteoclastogenesis is suppressed by osteoclastogenesis inhibitory factor.J. Paniagua — 2001
• 17β-Estradiol Stimulates Expression of Osteoprotegerin by a Mouse Stromal Cell Line, ST-2, via Estrogen Receptor-α.Ginette Michaud — 2001
• Osteoprotegerin inhibits in vitro mouse osteoclast formation induced by joint fluid from failed total hip arthroplasty.Raúl Martín Berrio — 2001
• APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosisMiguel Batllori — 2001
• Serum measurement of osteoprotegerin--clinical relevance and potential applications.John C. Eidson, Stan Woods — 2001
• Macrophage colony-stimulating factor and receptor activator NF-kappaB ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro.Laurent Hubert — 2002
• Co‐expression of CD30 ligand and interleukin 4 (IL‐4) receptors by acute myeloid leukaemia blasts is associated with the expansion of IL‐4‐producing CD30+ normal T cellsFrancesca Maria Rossi, Massimo Degan, Francesca Tassan Mazzocco — 2002
• Molecular mechanisms of cancer painErdem Topsakal, John L. Volakis — 2002
• U0126 and PD98059, Specific Inhibitors of MEK, Accelerate Differentiation of RAW264.7 Cells into Osteoclast-like Cells*Л. В. Гришакова, В. Ю. Гришаков — 2002
• Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells.Naoki Murabayashi — 2002
• Effect of IL-12 on TNF-α-Mediated Osteoclast Formation in Bone Marrow Cells: Apoptosis Mediated by Fas/Fas Ligand Interaction1Hideki Kitaura, Noriko Nagata, Yuji Fujimura — 2002
• Induction of Osteoclast Differentiation by Runx2 through Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Osteoprotegerin Regulation and Partial Rescue of Osteoclastogenesis in Runx2–/– Mice by RANKL Transgene*Georgia Clarke — 2003
• T‐Cells Mediate an Inhibitory Effect of Interleukin‐4 on OsteoclastogenesisDanijela Mirosavljevic, J Quinn, Jan Elliott — 2003
• Effects of Externally Applied, Cyclical, Low Magnitude Forces on Orthodontic Tooth Movement in RatsElizabeth Clair Blake — 2010
• Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virus.Ines Hartwig, Phedon Nicolaides — 2003
• Identification of RANKL in Osteolytic Lesions of the Facial Skeleton正知 堀江 — 2004

Related papers

• The Roles of CD28 and CD40 Ligand in T Cell Activation and Tolerance1Kimberly C. Howland, Lara J. Ausubel, Cheryl A. London — 2000
• CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.Caroline Johnson‐Léger — 1998
• CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L.S Shinde, Yan Wu, Yao Guo — 1996
• Foxp3+ regulatory T cells are activated in spite of B7‐CD28 and CD40‐CD40L blockadeIsabel Vogel, Bert Verbinnen, Wim Maes — 2013
• IN VITRO ANALYSIS OF CD40-CD154 AND CD28-CD80/86 INTERACTIONS IN THE PRIMARY T-CELL RESPONSE TO ALLOGENEIC “NON PROFESSIONAL” ANTIGEN PRESENTING CELLSJoseph Laning, Jennifer E. Deluca, Cary Isaacs — 2001
• IL-2 and IL-15 Regulate CD154 Expression on Activated CD4 T Cells1Søren Skov, Mark Bonyhadi, Niels Ødum — 2000
• Human follicular dendritic cells enhance cytokine-dependent growth and differentiation of CD40-activated B cells.Géraldine Grouard, Odette de Bouteiller, Jacques Banchereau — 1995
• Dendritic cells capable of stimulating T cells in germinal centresGéraldine Grouard, Isabella Durand, Luis Filgueira — 1996
• Functional CD40 antigen on B cells, dendritic cells and fibroblasts.Jacques Banchereau, Bertrand Dubois, Jérôme Fayette — 1995